- Home
- MREO
as 05-30-2025 4:00pm EST
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
| Founded: | 2015 | Country: | United Kingdom |
| Employees: | N/A | City: | LONDON |
| Market Cap: | 424.5M | IPO Year: | N/A |
| Target Price: | $7.71 | AVG Volume (30 days): | 943.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.31 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.57 - $5.02 | Next Earning Date: | 05-13-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | 54.91% |
Latest Mereo BioPharma Group plc News
MREO Breaking Stock News: Dive into MREO Ticker-Specific Updates for Smart Investing
Simply Wall St.
16 days ago
We're Not Very Worried About Mereo BioPharma Group's (NASDAQ:MREO) Cash Burn Rate
GlobeNewswire
18 days ago
Mereo BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Highlights
Insider Monkey
a month ago
Mereo BioPharma Group plc (MREO): A Bull Case Theory
Insider Monkey
a month ago
Is Mereo BioPharma Group (NASDAQ:MREO) the Best Biotech Penny Stock to Buy According to Hedge Funds?
MT Newswires
2 months ago
JPMorgan Initiates Coverage on Mereo BioPharma Group With Overweight Rating, $7 Price Target
GlobeNewswire
2 months ago
Mereo BioPharma Reports Full Year 2024 Financial Results and Provides Corporate Highlights
Zacks
2 months ago
MEREO BIOPHARMA (MREO) Upgraded to Buy: What Does It Mean for the Stock?
Simply Wall St.
3 months ago
Exploring High Growth Tech Stocks In The US Market
Compare MREO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MREO Mereo BioPharma Group plc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.